CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Option exercise | +938 | 3,329 | ||
| 2022-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Grant or award · Stock Option (Right to Buy) | +37,200 | 37,200 | ||
| 2022-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Grant or award · Restricted Stock Units | +10,440 | 10,440 | ||
| 2022-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Option exercise · Restricted Stock Units | −938 | 2,812 | ||
| 2022-03-08 | Roberts Darryl EVP, OPERATIONS & PRODUCT DEV. | Grant or award · Restricted Stock Units | +17,024 | 17,024 | ||
| 2022-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Option exercise | +4,072 | 31,775 | ||
| 2022-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +138,770 | 138,770 | ||
| 2022-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Grant or award · Restricted Stock Units | +37,788 | 37,788 | ||
| 2022-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −4,072 | 12,216 | ||
| 2022-03-08 | LLOYD RONALD K. PRESIDENT AND CEO | Grant or award · Restricted Stock Units | +39,894 | 39,894 | ||
| 2022-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Option exercise | +782 | 5,334 | ||
| 2022-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +8,700 | 8,700 | ||
| 2022-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −782 | 2,343 | ||
| 2022-03-08 | Riebman Jerome CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +14,758 | 14,758 | ||
| 2022-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise | +1,288 | 8,140 | ||
| 2022-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +8,700 | 8,700 | ||
| 2022-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −1,288 | 3,862 | ||
| 2022-03-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +13,874 | 13,874 |
Page 14 of 17 · 330 trades